{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"58.0","upperLimit":"74.0","value":"66.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"142"}],"units":"Participants"}],"description":"Percentage of patients who were event free at 3 years among those on Standard VCR dosing who did not undergo Hematopoietic Stem Cell Transplant (SCT).","dispersionType":"95% Confidence Interval","groups":[{"description":"Standard VCR dosing (1.5 mg/m\\^2, max 2 mg)","id":"OG000","title":"Regimen A: Standard Vincristine Dosing"}],"paramType":"NUMBER","populationDescription":"The analysis is limited to eligible patients on regimen A (Standard VCR dosing) who did not undergo SCT.","reportingStatus":"POSTED","timeFrame":"3 years after enrollment","title":"Event Free Survival. EFS","type":"PRIMARY","unitOfMeasure":"percentage of participants EFS at 3 yrs3"}